NDC50445-0222-01: INSULIN HUMAN ISOPHANE SUSPENSIO.
INSULIN HUMAN ISOPHANE SUSPENSIO. Key specifications include special_features: DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN, raw_material_source: PORK PANCREAS, primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, primary_container_content_quantity: 10.000 MILLILITERS, active_medicament_medicinal_strength: 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-243-7919, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN |
| raw_material_source | PORK PANCREAS |
| primary_container_type | VIAL |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER |
| NSN | 6505-01-243-7919 |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER |
| RAW MATERIAL SOURCE | PORK PANCREAS |